Dabur To Withdraw ‘Anti-bacterial’ Claims from Toothpaste Labels

Dabur India Ltd has told the Bombay High Court that it will withdraw terms like “anti-inflammatory,” “anti-bacterial,” and “analgesic” from the labels of its two toothpaste products, Dabur Meswak Toothpaste and Dabur Herb1 Anti-Bacterial Toothpaste Tulsi, with effect from June 2025. (Dabur India Ltd.v State of Maharashtra.)

The decision was taken following concerns raised by the Maharashtra government’s Food and Drug Administration regarding the legality of these claims.

A Bench of Justices GS Kulkarni and Advait M Sethna accepted Dabur’s undertaking on March 26 and disposed of Dabur’s plea in this regard.

“The statement made on behalf of the petitioner that the petitioner product ‘Dabur Meswak Toothpaste’ and “Dabur Herb’1 Anti-Bacterial Toothpaste Tulsi” will not bear the words ‘anti- inflammatory’ and ‘anti-bacterial’ and ‘analgesic’ respectively with effect from June 2025 stand accepted as an undertaking to the court,” the Bench said.

The case stemmed from an order passed on January 29 by the Commissioner of the Food and Drug Administration directing Dabur to amend the labels of their toothpastes to ensure compliance with statutory provisions.

The order said that the claims made on the labels were legally incorrect, although it acknowledged that the products were not hazardous to health.

Dabur was instructed to revise the labels before the restricted stock could be released.

Dabur then approached the High Court.

During the proceedings, Senior Advocate Ravi Kadam, appearing for Dabur, stated that the company would voluntarily discontinue using the disputed terms and had already initiated the process to revise the labels and packaging.

Dabur confirmed that the new labels would be in circulation by June 2025, following a detailed process involving design, printing and distribution.

The Court accepted Dabur’s undertaking and held that the disputed products could be sold until May 31 but could not be marketed with the contested labels after June 1.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines